stockrowAxoGen, Inc.
AXGN Healthcare Medical Devices
AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +163.2%
- Free cash flow
- +995.0%
- Total debt
- −73.1%
Quarter to September 2026, against a year earlier
Follow AXGN
Alert me
AxoGen, Inc. (AXGN) Book value per share
AxoGen, Inc.'s book value per share at the end of fiscal 2025 was 2.8×, up 19.2% from 2.3× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 9.0×. Over the past ten years it has ranged from 0.3× (fiscal 2015) to 4.0× (fiscal 2018); the current reading is higher than 73% of that period. AxoGen, Inc. ranks 39th of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 2.8× | 19.18% |
| FY2024 | 2.3× | 5.23% |
| FY2023 | 2.2× | (7.04%) |
| FY2022 | 2.4× | (12.11%) |
| FY2021 | 2.7× | (11.38%) |
| FY2020 | 3.1× | (8.52%) |
| FY2019 | 3.4× | (14.92%) |
| FY2018 | 4.0× | 423.87% |
| FY2017 | 0.8× | 55.49% |
| FY2016 | 0.5× | 54.63% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 9.0× | 87.21% |
| Jun 2026 | 4.8× | 1.25% |
| Mar 2026 | 4.7× | 69.59% |
| Dec 2025 | 2.8× | 7.69% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UFPT UFP Technologies, Inc. compare | 62.7× |
| ITGR Integer Holdings Corporation compare | 50.7× |
| INSP Inspire Medical Systems, Inc. compare | 28.6× |
| TMDX TransMedics Group, Inc. compare | 15.9× |
| NEOG Neogen Corporation compare | 9.6× |
| AXGN AxoGen, Inc. | 9.0× |
| IRTC iRhythm Holdings, Inc. compare | 5.4× |
| ALMR Alamar Biosciences, Inc. compare | 4.4× |
| ESTA Establishment Labs Holdings Inc. compare | 0.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on AXGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement